Annexin Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 114.1%.

Top 20 shareholders own 82.25% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
25.9%	Mikael Lonn	89,716,060	kr26.9m	138%	no data
18.5%	Arne Andersson	64,041,911	kr19.2m	143%	no data
8.47%	Sebastian Jahreskog	29,348,380	kr8.8m	148%	no data
7.57%	Magnus Claesson	26,245,066	kr7.9m	144%	no data
6.34%	Lars Hallén	21,983,544	kr6.6m	0%	no data
2.77%	Nordnet AB (publ), Asset Management Arm	9,613,523	kr2.9m	123%	0.04%
2.55%	Thorbjörn Fridh	8,825,000	kr2.6m	0%	no data
2.17%	Mattias Willman	7,507,061	kr2.3m	156%	no data
1.94%	Avanza Fonder AB	6,740,524	kr2.0m	125%	no data
1.8%	Lars Hallen	6,240,000	kr1.9m	0%	no data
1.67%	Medirista Ab	5,783,918	kr1.7m	1,050%	no data
1.26%	Torbjörn Fridh	4,355,000	kr1.3m	0%	no data
0.68%	Frostskog Ab	2,369,296	kr710.8k	0%	no data
0.28%	Anders Haegerstrand	985,008	kr295.5k	181%	no data
0.18%	Carl-Fredrik Lindner	640,005	kr192.0k	357%	no data
0.061%	Uli Hacksell	210,000	kr63.0k	110%	no data
0.055%	Susan Suchdev	189,560	kr56.9k	175%	no data
0.05%	Henrik Palm	175,000	kr52.5k	0%	no data
0.014%	Anthon Jahreskog	47,649	kr14.3k	110%	no data
0.013%	Gisela Sitbon	44,100	kr13.2k	110%	no data